ZBH stock forecast: what analysts expect
Wall Street analysts covering Zimmer Biomet Holdings, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $107.57 — +9.9% versus the last price of $97.89. Targets reflect analyst opinion, not a guarantee.
ZBH historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in ZBH.
ZBH annual returns by year
Congress trading in ZBH
5 members of Congress have disclosed trading ZBH — 5 purchases and 5 sales worth an estimated $320,500. Most recent disclosure: Nov 28, 2022.
See who in Congress traded ZBH →Insider activity in ZBH
ZBH's own executives and directors have made 0 open-market purchases ($0) and 2 sales ($413,216) in the last 90 days, per SEC Form 4 filings. Most recent: May 29, 2026.
| May 29, 2026 | Yi Sang | Group President, Asia Pacific | Sell | $347,088 |
| May 29, 2026 | Yi Sang | Group President, Asia Pacific | Sell | $66,128 |
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
ZBH Key Statistics
ZBH in plain English
- P/E ratio (23.6) — how many dollars you pay for each $1 of ZBH's yearly profit. That's a fairly normal range.
- ROE (6.41%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (9.48%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.98%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
ZBH stock: frequently asked questions
What is Zimmer Biomet Holdings, Inc.'s stock price today?
Zimmer Biomet Holdings, Inc. (ZBH) last traded at $97.89 on the NYSE. Over the past 52 weeks the stock has traded between $79.12 and $108.29.
Is ZBH stock a buy or a sell?
Wall Street analysts' consensus rating on ZBH is "Buy", with an average 12-month price target of $107.57 — about +9.9% versus the current price of $97.89. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in ZBH 10 years ago be worth today?
A $1,000 investment in Zimmer Biomet Holdings, Inc. made 10 years ago would be worth about $845 today (dividends reinvested) — a total return of -16%, or -1.7% per year.
Does ZBH pay a dividend?
Yes. Zimmer Biomet Holdings, Inc. currently pays a dividend yielding about 0.98% per year at today's share price.
What is ZBH's P/E ratio?
ZBH trades at a trailing price-to-earnings ratio of 23.6, and 10.8 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade ZBH stock?
Yes — 5 members of Congress have disclosed trades in ZBH under the STOCK Act, totaling 5 purchases and 5 sales worth an estimated $320,500.
What is Zimmer Biomet Holdings, Inc.'s ticker symbol?
Zimmer Biomet Holdings, Inc. trades under the ticker symbol ZBH on the NYSE.
Compare ZBH with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.